CG Oncology, Inc. (CGON) vs Mirum Pharmaceuticals, Inc. (MIRM)
- CG Oncology, Inc. CGON 59.79 −3.35%
- Mirum Pharmaceuticals, Inc. MIRM 80.18 −2.68%
CG Oncology, Inc. and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. CG Oncology, Inc. and Mirum Pharmaceuticals, Inc. are of similar size ($5.5B and $5.4B). CG Oncology, Inc. grew revenue faster over the last twelve months: 840.8% against 44.0%. Mirum Pharmaceuticals, Inc. has the higher net margin (−139.2% vs −3,602.7%) and the higher return on invested capital (−173.0% vs −4,111.6%). Across the 16 metrics below, Mirum Pharmaceuticals, Inc. leads on 10 and CG Oncology, Inc. on 6.
Valuation
Profitability
| Metric | CGON | MIRM | Biotechnology median |
|---|---|---|---|
| Gross margin | (85.20%) | 81.72% | 65.16% |
| Operating margin | (4,056.18%) | (134.93%) | 0.00% |
| Net margin | (3,602.68%) | (139.18%) | 0.00% |
| Free cash flow margin | (2,879.62%) | (44.29%) | 0.00% |
| Return on equity | (26.41%) | (702.97%) | (56.36%) |
| Return on assets | (25.11%) | (97.15%) | (48.04%) |
| Return on invested capital | (4,111.64%) | (172.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack